Join us for the first annual DART symposium.

The symposium will consist of speakers including Dr. Stacey Rudd from The University of Melbourne presenting "Metal Radionuclides in Theranostics; Past, Present and Future Perspectives". We'll also hear from the DART Deputy Directors, the postdoctoral fellows, and representatives from our ANSTO, Cyclotek, iPHASE, and Liverpool Hospital partners.

Both days will offer a blend of educational talks and professional skill development sessions.

Symposium Schedule:

Tuesday, 9 September

Wednesday, 10 September

9:00a - Networking and Welcome

9:30a - Keynote

10:30a - Morning Tea / Philosophers' Walk

11:00a - Session 1

12:30p - Lunch [on own]

2:00p - Session 2

3:30p - Professional skills development

[6:30p - Informal Dinner - local venue]

9:30a - Session 3

11:00a - Morning Tea

11:15a - Professional skills development

12:30p - Lunch

2:00p - Moodle workshop [DART participants only]

[3:00p - End]

Talks:

Keynote: "Metal Radionuclides in Theranostics; Past, Present and Future Perspectives" presented by Stacey Rudd, University of Melbourne

Nuclear medicine has existed since the 1940s, but the clinical approval of a handful of new metal-based radiopharmaceutical agents in the last few years has thrust the field into the spotlight. Now that radiopharmaceuticals have caught everyone’s attention, what are the future directions in this rapidly growing area? This presentation will give an overview of the history of metal radiopharmaceuticals, highlighting some of the field’s successes and failures over the last few decades, as well as exploring emerging ideas for the next steps in radiopharmaceutical development. Using examples from my own research, I will present a chemist’s perspective of the development of radiopharmaceutical agents, from initial chemical synthesis through to clinical translation.

*NOTE: Sessions information may change. Speakers may change sessions and ordering. The information below will be updated to reflect any changes.

Session 1:

"Diagnostic Imaging and Therapy with Radioactive Copper Complexes" presented by Paul Donnelly, University of Melbourne

"Basic Principals of Radiopharmaceutical Development" presented by Ben Fraser, ANSTO

"Deceptively Challenging – Manufacturing F-18 Radiopharmaceuticals in a Public Hospital" presented by Nigel Lengkeek, Liverpool Hospital

Session 2:

"Tumour-Selective Metal Chelators for Multiple Theranostic Applications" presented by Lou Rendina, University of Sydney

"Tuning the Pharmacokinetic Behaviour of Radiolabelled Immunoconjugates Through Modification of Bispidine Ligands" presented by Adam Kennedy, Monash University

"Cyclotek: An introduction to Radiopharmaceutical Manufacturing" presented by Cyclotek

Session 3:

"From Bond to Bedside: MBI’s Integrated Pathway of Discovery, Infrastructure, and Education" presented by Maggie Aulsebrook, Monash University

"Tumour-Targeted Alpha Particle Therapy with Actinium-225-Labelled Antibodies" presented by Katherine Morgan, University of Melbourne

"Myocardial Perfusion Imaging Using MC-1 Inhibitors - Background and Future Plans" presented by Amit Hestron, University of Sydney

"Radiochemistry Automation made in Australia - Two Decades of Innovation" presented by Christian Wichmann, iPHASE